Skip to main content

Breakthrough Discovery: Two Common Heart Drugs Could Reverse Fatty Liver Disease, Study Finds

Fatty liver disease, now called Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), affects nearly 40% of adults worldwide—and the numbers are climbing fast. Often silent in its early stages, MASLD can progress to life-threatening conditions like cirrhosis or liver cancer if left untreated.

But here’s the hopeful twist: researchers have discovered that a combination of two common heart drugs might actually reverse fat buildup in the liver, offering a potential breakthrough for millions.

A Surprising Discovery

A recent study published in Pharmacological Research found that pemafibrate, a drug used to lower blood lipids, and telmisartan, a common blood pressure medication, significantly reduced liver fat when used together.

In experiments using rats and zebrafish, scientists at the University of Barcelona observed that this drug duo not only decreased fat accumulation but did so at half the normal dosage—reducing potential side effects.

Dr. Marta Alegret, the study’s lead author, explained:

“We demonstrated that telmisartan and pemafibrate, alone or combined, effectively reduce liver lipid levels. What’s exciting is that the combination, even at low doses, worked just as well as using either drug alone.”

This could mean a new, safer way to treat fatty liver disease in the future.

Why Fatty Liver Disease Matters

MASLD—previously known as nonalcoholic fatty liver disease—is closely linked to unhealthy diets, obesity, insulin resistance, and inflammation. Many people don’t know they have it until it’s advanced.

Doctors say that losing just 5–10% of body weight can help reverse early stages of the condition, but for those who struggle with weight loss or lifestyle changes, effective drug treatments have been limited.

That’s where this new discovery could make a huge difference. Since both pemafibrate and telmisartan are already widely used and considered safe for heart conditions, repurposing them could speed up clinical trials and lower development costs.

Dr. Cheng-Han Chen, a U.S.-based cardiologist, told Medical News Today:

“Developing new drugs is expensive and risky. But repurposing drugs that have already proven safe for other uses could lead to faster, more cost-effective treatments for diseases like MASLD.”

How the Combination Works

The two drugs attack liver fat from different angles:

  • Pemafibrate boosts the body’s ability to break down lipids.
  • Telmisartan helps block fat synthesis in the liver while lowering blood pressure.

Together, they deliver a double punch—reducing fat storage while improving metabolic health.

What Comes Next

While these results are promising, researchers caution that the findings are still in the early stages. Human trials are needed to confirm whether the same effects occur outside of the lab.

Dr. Alegret noted:

“Our results are encouraging, but we can’t yet recommend these drugs for treating MASLD until larger clinical studies are done.”

Still, some early clinical reports already suggest improvements in liver health markers with either drug alone, raising hopes that combination therapy could soon offer a real-world solution.

The Bottom Line

With MASLD now affecting over one-third of adults globally, this discovery could mark a turning point in liver disease management. If proven effective in humans, this heart drug duo could become a low-cost, readily available treatment for millions at risk.

Until then, experts remind everyone that healthy eating, regular exercise, and maintaining a balanced weight remain the best defense against fatty liver disease.

Have you or someone you know struggled with fatty liver disease? Share your thoughts or questions in the comments below — and don’t forget to follow for more updates on breakthrough medical research!


Comments

Popular posts from this blog

Tragic Bet: Young Man Dies After Lifting 4 Cement Bags in Dare

What started as a harmless dare among friends ended in heartbreak for one young man. Meet Gbenga, who lost his life after attempting to lift four bags of cement in a bet. The Dare That Backfired Last Saturday, Gbenga and his boys were having fun, challenging each other to prove strength and bravery. The prize? Their mobile phones. The task? Lift four cement bags each weighing roughly 50 kg, totaling 200 kg, almost triple the strain an average person’s body expects to take. Gbenga, motivated by bravado and peer pressure, accepted the challenge. In a shocking turn, he successfully lifted the load, but immediately collapsed. His body couldn’t take the strain reports say his spine and nerves gave way, leaving him unable to move or speak. The Aftermath & Desperation Friends panicked. They tried everything pouring water on him, pulling him up, begging him to recover. But nothing worked. Bruised pride and adrenaline weren’t enough to save him. By Wednesday, Gbenga had passed on, leaving h...

Finally! Davido Opens Up On His 'Biggest Regret' With Chioma

In a shocking and heartfelt confession, Afrobeats superstar David Adeleke, popularly known as Davido, has revealed that his biggest regret was a fight he had with his wife, Chioma. The '5IVE' hitmaker, who recently tied the knot with his long-time partner, opened up about the emotional moment on a throwback episode of the popular ABTalks podcast. Davido, who is set to grace the stage at the Coachella 2026 Music Festival, admitted he felt "highly disappointed" in himself over the incident. According to the star, it was the only time in a long while that he felt such a deep sense of personal failure. "I Could Have Done Better" During the interview, podcast host Anas Bukhash asked the multiple award-winning musician to share a time when he felt the most disappointed in himself. Without hesitation, Davido's answer was both raw and honest. "Probably, when my wife, Chioma, first had like a little rift," he confessed. "I thought I could have done...

Burial Shock: See The Widow Who Wore Red Lipstick To Funeral

You need to hear this! A massive family drama has erupted across social media after a Nigerian woman reportedly refused to perform the traditional mourning rites for her late husband. ​The reason? He passed away while he was with his sidechic ! ​This story is currently trending and has sparked a heated debate online. Did the wife go too far, or was she simply serving the kind of pepper that was served to her marriage? ​The Shocking Funeral Entrance ​According to an anonymous post that went viral, the entire family was left completely stunned by the widow's actions during the burial ceremony . ​This was no weeping, wailing woman dressed in black. ​Instead, she showed up with the sass and confidence of a queen. Sources claim she attended the event rocking a bold, bright pepper red lipstick . Imagine the audacity! ​'Call The Sidechic To Mourn Him!' ​But the lipstick was just the beginning of the shocker. ​The real bombshell dropped immediately after the deceased was lowered ...